4-(3,6-Diamino-acridin-9-ylamino)-N-methyl-benzenesulfonamide

ID: ALA35072

PubChem CID: 9977885

Max Phase: Preclinical

Molecular Formula: C20H19N5O2S

Molecular Weight: 393.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNS(=O)(=O)c1ccc(Nc2c3ccc(N)cc3nc3cc(N)ccc23)cc1

Standard InChI:  InChI=1S/C20H19N5O2S/c1-23-28(26,27)15-6-4-14(5-7-15)24-20-16-8-2-12(21)10-18(16)25-19-11-13(22)3-9-17(19)20/h2-11,23H,21-22H2,1H3,(H,24,25)

Standard InChI Key:  AVPYNABDMYYIMV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    9.3667   -8.6417    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.5292  -11.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5375  -12.7875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2417  -11.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8167  -11.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2500  -12.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8167  -12.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5250  -10.3042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6542   -9.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9667  -12.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1042  -12.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9542  -11.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1042  -11.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3667   -7.8167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3667   -9.4667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1917   -8.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6625   -9.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9375   -8.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2375   -9.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3917  -12.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6792  -12.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3917  -11.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6750  -11.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4042  -12.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6750  -12.7917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9500  -10.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2292   -9.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6042   -7.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  8  1  0
  3  7  1  0
  4  2  2  0
  5  2  1  0
  6  4  1  0
  7  5  1  0
  8 19  1  0
  9  1  1  0
 10  6  1  0
 11  7  2  0
 12  4  1  0
 13  5  2  0
 14  1  2  0
 15  1  2  0
 16  1  1  0
 17  9  2  0
 18  9  1  0
 19 27  1  0
 20 22  2  0
 21 23  1  0
 22 13  1  0
 23 12  2  0
 24 21  1  0
 25 20  1  0
 26 17  1  0
 27 18  2  0
 28 16  1  0
 19 26  2  0
  3  6  2  0
 11 20  1  0
 10 21  2  0
M  END

Associated Targets(Human)

Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II (1334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2 DNA topoisomerase 2 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.47Molecular Weight (Monoisotopic): 393.1259AlogP: 3.20#Rotatable Bonds: 4
Polar Surface Area: 123.13Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.89CX Basic pKa: 10.19CX LogP: 1.68CX LogD: 0.44
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.31Np Likeness Score: -1.05

References

1. Gamage SA, Tepsiri N, Wilairat P, Wojcik SJ, Figgitt DP, Ralph RK, Denny WA..  (1994)  Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.,  37  (10): [PMID:8182707] [10.1021/jm00036a014]

Source